Cue Care™ Nationwide to Provide Same-Day, At-Home, Test-to-Treatment Service for COVID-19

 Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company that puts diagnostic information at the center of care, today announced the nationwide launch of Cue Care™, its same-day, at-home, test-to-treatment solution. Patients in any of the 50 states who test positive using Cue's COVID-19 tests can now use the Cue Health App to:

1. Consult virtually and on-demand with a healthcare professional about their test result;

2. Obtain an e-prescription - if medically indicated - for a medication to treat the virus; and

3. Get the medication delivered - usually within hours* - conveniently and safely at home or the medication will be made available for pickup at their local pharmacy.

Within a few weeks, Cue Health anticipates expanding this new service to patients who test positive on any COVID-19 test, including at-home antigen tests. The Cue Care antiviral delivery service costs between $79 and $99 and includes a televisit with a healthcare professional and delivery of a medication, the cost of which is currently covered by the U.S. Department of Health and Human Services (HHS). According to HHS, early COVID-19 treatment can help improve patient outcomes, reduce hospitalization, and even save lives.

https://finance.yahoo.com/news/cue-health-launches-cue-care-131500431.html